Rankings
▼
Calendar
PCVX
Vaxcyte, Inc.
$8B
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$18M
Net Income
-$17M
EPS (Diluted)
$-4.83
Cash Flow
Operating Cash Flow
-$14,963
Free Cash Flow
-$16,185
Stock-Based Comp.
$390
Balance Sheet
Total Assets
$40M
Total Liabilities
$9M
Stockholders' Equity
$31M
Cash & Equivalents
$36M
← FY 2018
All Quarters
PCVX FY 2017 Earnings — Vaxcyte, Inc. Revenue & Financial Results | Market Cap Arena